ATF3 and colorectal carcinoma: Research has demonstrated that inhibiting activating transcription factor 3 (ATF3) and cystathionine β‐synthase (CBS) can target the mitochondrial cycle, increasing the susceptibility of CRC cells to ferroptosis.